Majid Alhomrani
Papers
1
Total Citations
4
H-Index
1
About
Majid Alhomrani is a pioneering researcher at the intersection of neuroscience, drug safety, and advanced biofabrication. His work centers on understanding how widely prescribed pharmaceuticals affect neural development, employing cutting-edge 3D cell culture and bioprinting technologies to model complex biological systems. Alhomrani’s most notable contribution is his groundbreaking 2024 study on pregabalin, a common drug for neurological disorders, where he investigated its impact on embryonic cortical neurons. By integrating ultrashort self-assembling peptides with high-throughput robotic 3D bioprinting, he created sophisticated neuronal models that revealed previously unknown developmental risks—a critical insight for prenatal medicine. This innovative approach, which bridges tissue engineering and neuropharmacology, has already garnered attention (4 citations in its first year) for its potential to transform preclinical drug screening. Alhomrani’s work exemplifies how advanced biomaterials and automation can address pressing questions in developmental neuroscience, positioning him as a rising leader in the field of 3D cell culture and neurotoxicology.
Research Focus
Key Achievements
Top Papers
- 1